MTHFD1 and lung adenocarcinoma: SHMT2 and methylenetetrahydrofolate dehydrogenase, MTHFD2, key enzymes of the mitochondrial folate cycle, were likewise found to be overexpressed in lung adenocarcinoma and/or associated with poor prognosis [23–25].